SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending due to discussions around delivery numbers and Q4 guidance, with some investors expressing concerns about profitability timelines after recent announcements. The community is debating the impact of potential government policy changes on EV subsidies, as well as NIO's long-term strategy and the competitive landscape within the Chinese EV market. Bullish investors highlight the company's battery swap technology and expansion plans, while bears cite concerns over cash flow and profitability.

Copart, Inc. engages in the provision of online auctions and vehicle remarketing services. The firm offers vehicle sellers a full range of services to process and sell vehicles primarily over the internet through Virtual Bidding Third Generation Internet auction-style sales technology. It sells vehicles principally to licensed vehicle dismantlers, rebuilders, repair licensees, used vehicle dealers, exporters and at certain locations, and the public. The company’s services include online seller access, salvage estimation services, estimating services, end-of-life vehicle processing, virtual insured exchange, transportation services, vehicle inspection stations, on-demand reporting, DMV processing, and vehicle processing programs. It operates through the United States and International segments. The company was founded by Willis J. Johnson in 1982 and is headquartered in Dallas, TX.

Copart, Inc.

Copart ($CPRT) is trending as investors discuss its potential as a long-term compounder in the salvage auction niche, citing its strong competitive advantages and AI integration. Community members are debating whether it's currently oversold and presenting a buying opportunity, with some pointing to technical indicators and analyst price targets while highlighting key catalysts that could lift the stock price. Others caution about rising costs, competition, and potential risks from technological shifts.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending due to recent partnerships and presentations highlighting its material-verification technology, leading to a surge in retail interest and high volatility as traders debate the potential for a short squeeze versus an imminent offering. Community members are actively discussing price targets, dilution risks, and potential trading strategies amid the stock's significant gains. The broader context involves the increasing importance of supply chain verification and Dubai's role as a hub for precious metals trading.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA) is trending due to community excitement around its potential as foundational infrastructure for TradFi, emphasized by its high throughput and compliance-aware design. Investors are actively discussing the token's value proposition in comparison to major platforms like Amazon, Google, and Microsoft, viewing KTA as a targeted bet on the future of financial plumbing. The community also highlights potential partnerships, particularly with Stripe, as a key catalyst.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is trending as investors weigh the implications of its recent acquisition of Astria Therapeutics and monitor key upcoming events. The community is actively discussing the potential for a revenue boost following pediatric approval for Orladeyo, the impact of the Astria merger on their HAE pipeline, and short squeeze opportunities. Broader discussions involve analyst ratings, profitability prospects, and the overall biotech landscape.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust ($SLV) is trending as the silver market shows signs of breaking out, with community members noting significant price jumps and discussing a potential #silversqueeze. Industrial demand for silver in EVs and AI is also a key talking point, coupled with supply remaining relatively flat. Some traders suggest a rotation from crypto into precious metals is contributing to the increased interest.

Vanguard Group, Inc. - Vanguard FTSE Emerging Markets ETF

Vanguard FTSE Emerging Markets ETF

VWO is trending as investors assess opportunities in emerging markets amidst fluctuating global conditions. Community discussions revolve around diversification strategies, potential for growth outside the US, and the impact of currency fluctuations. Some traders are highlighting technical patterns and recent options activity, contributing to the increased attention.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

HYMC is trending as precious metals prices surge, with silver nearing all-time highs, leading to increased interest in the mining stock; The community is discussing the potential impact of rising silver prices and a debt-free balance sheet, with some speculating about a short squeeze and future mining operations, while others debate AMC's investment and its potential profitability.

Sprott Physical Silver Trust - Units

Sprott Physical Silver Trust ET

PSLV is trending as silver prices surge, driven by industrial demand from AI and EVs, alongside expectations of Federal Reserve rate cuts. Community discussions focus on PSLV as a way to hold physical silver, rather than paper silver ETFs like SLV, with some anticipating a significant squeeze. Silver's role as both a monetary and industrial asset is being emphasized, with bullish sentiment toward potential long-term gains.

ProShares Trust - ProShares Short Bitcoin ETF

ProShares Short Bitcoin Strategy ETF

BITI is trending as traders discuss potential bearish signals for Bitcoin, with some anticipating a significant pullback. Community members are weighing the possibilities of shorting BTC, while others highlight technical indicators suggesting it's overbought. The ETF's inverse relationship with Bitcoin fuels speculation on its potential performance amid market uncertainty and upcoming events.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jefferies Financial Group Inc. Makes New Investment in BioCryst Pharmaceuticals, Inc. $BCRX

Jefferies Financial Group Inc. purchased a new stake in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with...

Neo Ivy Capital Management Takes $810,000 Position in BioCryst Pharmaceuticals, Inc. $BCRX

Neo Ivy Capital Management bought a new position in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Free Report) in the 2nd quarter, according to the company in its most recent disclosure...

SG Americas Securities LLC Raises Stake in BioCryst Pharmaceuticals, Inc. $BCRX

SG Americas Securities LLC lifted its stake in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Free Report) by 441.5% during the 2nd quarter, according to the company in its most recent...

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the fourteen analysts that are presently covering the firm, MarketBeat...

M&G PLC Makes New Investment in BioCryst Pharmaceuticals, Inc. $BCRX

M&G PLC acquired a new stake in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and...

Astria Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today reported financial results for the...

BioCryst Pharmaceuticals, Inc. $BCRX Stake Lifted by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. increased its position in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Free Report) by 20.7% during the 2nd quarter, according to the company...

HC Wainwright Has Positive Estimate for BCRX FY2025 Earnings

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX - Free Report) - Stock analysts at HC Wainwright increased their FY2025 earnings estimates for BioCryst Pharmaceuticals in a research note issued to...

Citizens Jmp Has Lowered Expectations for BioCryst Pharmaceuticals (NASDAQ:BCRX) Stock Price

Citizens Jmp reduced their price objective on BioCryst Pharmaceuticals from $27.00 to $25.00 and set a "market outperform" rating for the company in a research note on Wednesday...

Ardelyx (ARDX) Reports Break-Even Earnings for Q3

Ardelyx (ARDX) delivered earnings and revenue surprises of +100.00% and +10.52%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

$AMZN

$MSFT

$GOOGL

$ORCL

Which cloud infrastructure stock offers the best long-term opportunity right now?

BCRX
Biocryst Pharmaceuticals Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest BCRX News

BCRXBiocryst Pharmaceuticals Inc.